Downregulation of ubiquitin E3 ligase TNF receptor-associated factor 7 leads to stabilization of p53 in breast cancer

Lixin Wang, Lei Wang, Shuping Zhang, Guangbo Qu, Daoqiang Zhang, Shitao Li, Sijin LiuOncology 2012 · DOI

Abstract

The tumor suppressor p53 is a master regulator of apoptosis and DNA repair. While p53 accumulation in cancer is often attributed to genetic mutations, many breast cancer cases exhibit high levels of wild-type p53. This study identifies TNF receptor-associated factor 7 (TRAF7) as a novel E3 ubiquitin ligase for p53. Downregulation of TRAF7 in breast cancer leads to the stabilization and cytosolic sequestration of p53, correlating with poor patient prognosis.

Introduction

Often termed the "guardian of the genome," p53 is typically maintained at low levels in healthy cells through MDM2-mediated degradation. In many cancers, p53 protein levels are elevated. While this is frequently due to TP53 mutations that stabilize a non-functional protein, a significant portion of breast cancer patients show high levels of wild-type p53. This research investigates the mechanisms behind this accumulation, identifying the E3 ligase TRAF7 as a critical missing link in p53 regulation.

Methods

The study utilized a multi-faceted approach:

  • Clinical Pathology: Immunohistochemical (IHC) staining of 66 breast tissue samples (30 benign, 36 malignant) was performed to assess p53 protein levels and localization.
  • Genomic Analysis: Exons 4–9 of the TP53 gene were sequenced to identify potential mutations.
  • Biochemical Assays: In vitro ubiquitination assays using purified proteins confirmed that TRAF7 directly attaches K48-linked ubiquitin chains to p53, signaling it for degradation.
  • Expression Profiling: TRAF7 mRNA and protein levels were compared between tumor and adjacent healthy tissues using qRT-PCR and Western blotting.
  • Survival Analysis: Findings were validated using a public dataset of 183 breast cancer patients (GEO ID: GSE 24450).

Key Results

The researchers found that 89% of malignant tumors were p53-positive by IHC, despite a lack of mutations in the TP53 gene. This accumulation was primarily cytosolic, effectively disarming p53 by preventing it from entering the nucleus to act as a transcription factor.

Figure 1: IHC staining (A) and quantitative analysis of integrated optical density (B) showing significantly higher p53 levels in malignant vs. benign breast tissues.

Concurrently, TRAF7 expression was significantly downregulated in malignant tissues. The study demonstrated that TRAF7 requires its RING finger domain to function as an E3 ligase for p53. Clinically, patients with low TRAF7 expression had significantly shorter overall survival, with the "TRAF7-low/p53-high" phenotype representing the poorest prognosis.

Discussion and Limitations

This study establishes TRAF7 as a direct regulator of p53 stability and a potential prognostic marker in breast cancer. However, some limitations remain. The sequencing was limited to exons 4–9, potentially missing mutations elsewhere. Additionally, the exact mechanism of TRAF7 downregulation—whether epigenetic, microRNA-mediated, or genomic—remains to be elucidated. Future work should explore whether restoring TRAF7 activity can reactivate the p53 pathway for therapeutic benefit.

Summary updated

Abstract

p53 is a key tumor suppressor and a master regulator of various signaling pathways, such as those related to apoptosis, cell cycle and DNA repair. In this study, we found a pronounced cytosolic accumulation of the p53 protein in a panel of breast cancer specimens. Several mutations lead to p53 accumulation by disruption of MDM2-mediated p53 degradation. However, gene sequencing revealed no p53 mutation in the majority of our samples. Through search for other possible p53 E3 ligases by mRNA and protein expression analysis, downregulation of TNF receptor-associated factor 7 (TRAF7) expression was found in these breast tumors. We further identified TRAF7 as an E3 ligase for K48-linked ubiquitination of p53 in vitro. These results suggested that the p53 accumulation was due to the defects of TRAF7-mediated ubiquitination. The downregulation of TRAF7 also correlated with poor prognosis in a breast cancer cohort. Collectively, TRAF7-mediated ubiquitination of p53 plays a critical role in breast cancer development, and these insights may aid in the development of novel therapeutic strategies for breast cancer.
BibTeX
@inproceedings{wang2012downregulation,
  author = {Lixin Wang and Lei Wang and Shuping Zhang and Guangbo Qu and Daoqiang Zhang and Shitao Li and Sijin Liu},
  title = {{Downregulation of ubiquitin E3 ligase TNF receptor-associated factor 7 leads to stabilization of p53 in breast cancer}},
  booktitle = {Oncology},
  year = {2012},
  doi = {10.3892/or.2012.2121},
}
Figure